thrombin receptor peptide sfllrnp has been researched along with Coronary Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bobbert, P; Bobbert, T; Rauch, U; Schultheiss, HP; Schütte, C; Steffens, D; Stellbaum, C | 1 |
Duffy, SJ; Holbrook, M; Keaney, JF; Swerdloff, PL; Vita, JA | 1 |
1 trial(s) available for thrombin receptor peptide sfllrnp and Coronary Disease
Article | Year |
---|---|
Effect of acute and chronic tea consumption on platelet aggregation in patients with coronary artery disease.
Topics: Adenosine Diphosphate; Coronary Artery Disease; Coronary Disease; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Humans; Lipids; Male; Middle Aged; Peptide Fragments; Platelet Aggregation; Tea | 2001 |
1 other study(ies) available for thrombin receptor peptide sfllrnp and Coronary Disease
Article | Year |
---|---|
Postmenopausal women have an increased maximal platelet reactivity compared to men despite dual antiplatelet therapy.
Topics: Adenosine Diphosphate; Aged; Arachidonic Acid; Aspirin; Blood Platelets; Clopidogrel; Coronary Disease; Female; Humans; Male; Middle Aged; Peptide Fragments; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Postmenopause; Prospective Studies; Sex Factors; Ticlopidine | 2012 |